Johnson Matthey PLC (LON:JMAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Johnson Matthey PLC (LON:JMATGet Free Report) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is GBX 1,993.33 ($26.07).

A number of equities analysts recently commented on the stock. Berenberg Bank reiterated a “hold” rating and issued a GBX 1,800 ($23.54) target price on shares of Johnson Matthey in a research report on Tuesday, June 11th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 2,400 ($31.38) price objective on shares of Johnson Matthey in a report on Monday, June 24th.

View Our Latest Stock Report on Johnson Matthey

Johnson Matthey Trading Up 1.1 %

JMAT stock opened at GBX 1,603 ($20.96) on Monday. Johnson Matthey has a one year low of GBX 1,428.50 ($18.68) and a one year high of GBX 1,917.07 ($25.07). The company has a market capitalization of £2.85 billion, a PE ratio of 2,763.79, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company’s 50 day moving average price is GBX 1,622.14 and its two-hundred day moving average price is GBX 1,687.47. The company has a debt-to-equity ratio of 63.15, a quick ratio of 0.76 and a current ratio of 1.45.

Insiders Place Their Bets

In other Johnson Matthey news, insider Stephen Oxley purchased 24 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, July 17th. The shares were bought at an average price of GBX 1,695 ($22.17) per share, for a total transaction of £406.80 ($531.97). Insiders have bought a total of 69 shares of company stock valued at $111,471 in the last quarter. Insiders own 0.60% of the company’s stock.

Johnson Matthey Company Profile

(Get Free Report

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.